On March 10, 2022 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported that it will present at the 34th annual Roth Conference on Monday, March 14, 2022, at 3:30 PM PT (Press release, Delcath Systems, MAR 10, 2022, View Source [SID1234609870]). A webcast of the presentation will be available at: View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To learn more or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].